Keyphrases
Parkinson's Disease
100%
Positron Emission Tomography
21%
Huntington's Disease
20%
Dystonia
17%
Alpha-synuclein (α-syn)
16%
Parkinsonism
15%
Nonhuman Primate
13%
Deep Brain Stimulation
13%
Levodopa
11%
Radioligand
10%
Striatal
10%
Cervical Dystonia
9%
Confidence Interval
9%
Manganese
9%
Unified Parkinson's Disease Rating Scale (UPDRS)
9%
Idiopathic Parkinson's Disease
9%
Alzheimer's Disease
9%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
9%
Dopamine
9%
Radiotracer
8%
Receptor Binding
7%
Neurodegenerative Diseases
7%
Parkinson Patients
7%
Patients with Parkinson's Disease
7%
Manganese Exposure
7%
D2 Receptor
6%
Vesicular Acetylcholine Transporter (VAChT)
6%
Age of Onset
6%
Striatum
6%
Macaque
6%
Movement Disorders
6%
Regional Cerebral Blood Flow (rCBF)
6%
Leucine-rich Repeat Kinase 2 (LRRK2)
5%
Pathophysiology
5%
Basal Ganglia
5%
Monkey
5%
Tremor
5%
Subthalamic nucleus
5%
Gait
5%
Odds Ratio
5%
Medicare Beneficiaries
5%
Parkinson's Disease Risk
5%
Functional Magnetic Resonance Imaging
5%
Baboon
5%
Welders
5%
Neuroscience
Parkinson's Disease
90%
Positron Emission Tomography
24%
Dystonia
18%
Fluorine-18
17%
Deep Brain Stimulation
15%
In Vivo
14%
Parkinsonism
14%
Huntington's Disease
13%
Positron Emission Tomography
11%
L-DOPA
11%
Receptor
10%
Subthalamic Nucleus
10%
Dopaminergic
10%
Alzheimer's Disease
10%
Radioligand
9%
Tremor
9%
Behavior (Neuroscience)
9%
Synuclein
8%
Stereotypic Movement Disorder
8%
In Vitro
8%
Basal Ganglia
7%
Spasmodic torticollis
7%
Putamen
7%
Neurodegenerative Disorder
7%
Amyloid Protein
7%
Receptor Binding
6%
Striatum
6%
Cerebellum
5%
Magnetic Resonance Imaging
5%
Functional Connectivity
5%
Functional Magnetic Resonance Imaging
5%